AR and prostate cancer: However, reports that decreased HECTD4 in prostate cancer leads to increased AR and MYC proteins and that increased AR/MYC is oncogenic in OSCC suggest that loss‐of‐function mutations in HECTD4 are oncogenic and may be a cause of carcinogenesis in elderly nonsmokers.